ZA949377B - Novel composition - Google Patents

Novel composition

Info

Publication number
ZA949377B
ZA949377B ZA949377A ZA949377A ZA949377B ZA 949377 B ZA949377 B ZA 949377B ZA 949377 A ZA949377 A ZA 949377A ZA 949377 A ZA949377 A ZA 949377A ZA 949377 B ZA949377 B ZA 949377B
Authority
ZA
South Africa
Prior art keywords
novel composition
novel
composition
Prior art date
Application number
ZA949377A
Inventor
John Edward O'mullane
Steven Poile
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA949377B publication Critical patent/ZA949377B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
ZA949377A 1993-11-27 1994-11-25 Novel composition ZA949377B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939324409A GB9324409D0 (en) 1993-11-27 1993-11-27 Novel composition

Publications (1)

Publication Number Publication Date
ZA949377B true ZA949377B (en) 1995-11-06

Family

ID=10745801

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949377A ZA949377B (en) 1993-11-27 1994-11-25 Novel composition

Country Status (6)

Country Link
EP (1) EP0730464A1 (en)
JP (1) JPH09505573A (en)
AU (1) AU1065395A (en)
GB (1) GB9324409D0 (en)
WO (1) WO1995014483A1 (en)
ZA (1) ZA949377B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595977A (en) * 1993-10-27 1997-01-21 Dumex-Alpharma A/S Salts of amino glycosides
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
FR2956322A1 (en) 2010-02-17 2011-08-19 Urgo Lab USE OF SYNTHETIC POLYSULFATE OLIGOSACCHARIDES AS DETERSION AGENTS OF A WOUND.
CN113274404A (en) * 2020-06-28 2021-08-20 天翊生物医药科技(天津)有限公司 New application of medical adsorption resin and helicobacter pylori eliminating medicine
CN116098863B (en) * 2023-03-20 2023-08-29 广东逸舒制药股份有限公司 Sulfosamine oral suspension and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1220818A (en) * 1967-10-31 1971-01-27 Mar Pha Soc D Etude Et D Expl New medicinal composition
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
GB9108080D0 (en) * 1991-04-15 1991-06-05 Smithkline Beecham Plc Pharmaceutical composition
GB9211148D0 (en) * 1992-05-26 1992-07-08 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
AU1065395A (en) 1995-06-13
GB9324409D0 (en) 1994-01-12
WO1995014483A1 (en) 1995-06-01
EP0730464A1 (en) 1996-09-11
JPH09505573A (en) 1997-06-03

Similar Documents

Publication Publication Date Title
HK1012284A1 (en) Novel composition
GB9318841D0 (en) Composition
ZA942052B (en) Tricritical point composition
GB9302130D0 (en) Cleasing composition
GB9310700D0 (en) Novel composition
GB9313274D0 (en) Composition
GB2281914B (en) Composition
GB9301289D0 (en) Novel composition
GB9324409D0 (en) Novel composition
ZA946967B (en) Lyophillisate composition
GB2282385B (en) Composition
GB9320370D0 (en) Frit-containing composition
GB2271999B (en) Novel composition
GB9321876D0 (en) Novel composition
GB9320598D0 (en) Composition
SI0727979T1 (en) Novel composition
GB9322288D0 (en) Novel composition
GB9308170D0 (en) Novel composition
GB9301136D0 (en) Novel composition
GB9317061D0 (en) Composition
SG48328A1 (en) Composition
GB9317222D0 (en) Composition
GB9317223D0 (en) Composition
GB9317063D0 (en) Composition
GB9318548D0 (en) Composition